COMPARISON OF THE PCR WITH THE CEFOXITIN DISC DIFFUSION TEST FOR DETECTION OF METHICILLIN RESISTANCE IN OXACILLIN RESISTANT COAGULASE-NEGATIVE STAPHYLOCOCCI (CONS)

被引:0
作者
Kilic, I. H. [1 ]
Ozaslan, M. [1 ]
Zer, Y. [2 ]
Karagoz, I. D. [1 ]
Mentes, O. [2 ]
Cengiz, B. [3 ]
Balci, I. [2 ]
机构
[1] Gaziantep Univ, Dept Biol, Gaziantep, Turkey
[2] Gaziantep Univ, Dept Microbiol, Gaziantep, Turkey
[3] Gaziantep Univ, Dept Phisiol, Gaziantep, Turkey
关键词
coagulase-negative staphylococci; methicillin resistance; PCR; cefoxitin disc diffusion test; UNITED-STATES HOSPITALS; BLOOD-STREAM INFECTIONS; INTENSIVE-CARE UNITS; ANTIMICROBIAL RESISTANCE; ANTIBIOTIC-RESISTANCE; SURVEILLANCE PROGRAM; SUSCEPTIBILITY; AUREUS; EPIDEMIOLOGY; DIAGNOSIS;
D O I
10.2478/V10133-010-0045-Z
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Nosocomial infections are a prevalent problem all over the world. Bacteraemias are the commonest types of infections and have high mortality and morbidity rates. S. epidermidis and S. aureus are the most frequently associated infectious agents with bacteriemia-acquired in hospital. It is common that these pathogens are resistant to methicillin that limits treatment alternatives. Several methods are developed to detect methicillin resistance rapidly and accurately. This study was aimed to compare the oxacillin and cefoxitin disc diffusion test with PCR for detection of methicillin resistance. Thirty-two CNS strains isolated from blood culture samples that were collected from hospitalized patients in ICUs of our hospital between October-December 2007 and determined to be resistant by oxacillin disc diffusion test, were included. Three strains were sensitive to cefoxitin and the rest of them were resistant. A total of 59.3% of oxacillin resistant strains and 55.2% of cefoxitin resistant strains were mecA positive. The detection of methicillin resistance by disc diffusion test is often false in a high percentage and therefore, especially in ICUs where critical patients are hospitalized, the usage of molecular techniques is more suitable.
引用
收藏
页码:1862 / 1865
页数:4
相关论文
共 32 条
  • [1] Akalin H, 2001, TURKISH J HOSP INFEC, V5, P5
  • [2] Antimicrobial resistance in isolates from inpatients and outpatients in the united states: Increasing importance of the intensive care unit
    Archibald, L
    Phillips, L
    Monnet, D
    McGowan, JE
    Tenover, F
    Gaynes, R
    [J]. CLINICAL INFECTIOUS DISEASES, 1997, 24 (02) : 211 - 215
  • [3] Detection of the mec-A gene and phenotypic detection of resistance in Staphylococcus aureus isolates with borderline or low-level methicillin resistance
    Bignardi, GE
    Woodford, N
    Chapman, A
    Johnson, AP
    Speller, DCE
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 37 (01) : 53 - 63
  • [4] Guidelines for the laboratory diagnosis and susceptibility testing of methicillin-resistant Staphylococcus aureus (MRSA)
    Brown, DFJ
    Edwards, DI
    Hawkey, PM
    Morrison, D
    Ridgway, GL
    Towner, KJ
    Wren, MWD
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 56 (06) : 1000 - 1018
  • [5] CHAMBERS H F, 1988, Clinical Microbiology Reviews, V1, P173
  • [6] Survey of infections due to Staphylococcus species:: Frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999
    Diekema, DJ
    Pfaller, MA
    Schmitz, FJ
    Smayevsky, J
    Bell, J
    Jones, RN
    Beach, M
    [J]. CLINICAL INFECTIOUS DISEASES, 2001, 32 : S114 - S132
  • [7] Nosocomial bloodstream infections in United States hospitals: A three-year analysis
    Edmond, MB
    Wallace, SE
    McClish, DK
    Pfaller, MA
    Jones, RN
    Wenzel, RP
    [J]. CLINICAL INFECTIOUS DISEASES, 1999, 29 (02) : 239 - 244
  • [8] Infection control in the ICU
    Eggimann, P
    Pittet, D
    [J]. CHEST, 2001, 120 (06) : 2059 - 2093
  • [9] ERMERTCAN S, 2003, INFEKSIYON DERGISI, V17, P437
  • [10] Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: Project ICARE phase 2
    Fridkin, SK
    Steward, CD
    Edwards, JR
    Pryor, ER
    McGowan, JE
    Archibald, LK
    Gaynes, RP
    Tenover, FC
    [J]. CLINICAL INFECTIOUS DISEASES, 1999, 29 (02) : 245 - 252